Abstract
A killer application? Recently, fully integrated full-body positron-emission tomography (PET) and magnetic-resonance imaging (MRI) scanners were brought to market, allowing simultaneous recording of complementary 3D data sets. By using bimodal PET/MRI probes (see figure), in vivo 3D mapping of various parameters with medical relevance could become feasible.
| Original language | English |
|---|---|
| Pages (from-to) | 12602-12606 |
| Number of pages | 5 |
| Journal | Chemistry - A European Journal |
| Volume | 19 |
| Issue number | 38 |
| DOIs | |
| State | Published - 16 Sep 2013 |
Keywords
- contrast agents
- gallium-68
- macrocyclic ligands
- magnetic resonance imaging
- positron emission tomography
- radiopharmaceuticals